Latest

Understand ALK fusion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

ALK Fusion Test for Lung Cancer: Gene Fusion, Positive Result, and Molecular Meaning

Understand BRAF V600E testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

BRAF V600E Test for Lung Cancer: Mutation Status, Positive Result, and Molecular Meaning

Learn how the carcinoembryonic antigen (CEA) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CEA Test for Lung Cancer: Tumor Marker Monitoring, High Levels, and Result Meaning

Learn how the cytokeratin 19 fragment 21-1 (CYFRA 21-1) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CYFRA 21-1 Test for Lung Cancer: Tumor Marker Levels and Disease Monitoring

Understand EGFR exon 20 insertion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Exon 20 Insertion Test: Lung Cancer Mutation Status and Molecular Meaning

Understand EGFR mutation testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Mutation Test for Lung Cancer: Exon 19, L858R, T790M, Mutation Status, and...

Diagnostics

Home Diagnostics Page 44

Learn how autosomal recessive carrier screening results combine with partner testing to define couple risk, residual risk, and reproductive options.

Autosomal Recessive Carrier Screening Test: Partner Risk and Results

Understand how DMD gene testing confirms Becker muscular dystrophy, detects deletions and sequence variants, predicts phenotype, and guides family care.

Becker Muscular Dystrophy Genetic Test: DMD Gene Mutations and Results

Learn how HBB genetic testing diagnoses beta-thalassemia, identifies carriers, clarifies partner risk, and explains positive, negative, and uncertain results.

Beta-Thalassemia Genetic Test: HBB Gene Mutations, Carrier Risk, and Results

Learn how BTD genetic testing and enzyme activity confirm profound or partial biotinidase deficiency, explain variants, and guide treatment and family risk.

Biotinidase Deficiency Genetic Test: BTD Gene Mutations and Results

Learn how ASPA carrier testing identifies Canavan disease risk, compares founder panels with full-gene testing, and guides partner and pregnancy decisions.

Canavan Disease Carrier Test: ASPA Gene, Carrier Risk, and Results

Understand how CYP21A2 testing confirms 21-hydroxylase-deficient CAH, resolves pseudogene and deletion complexity, and explains disease and carrier results.

Congenital Adrenal Hyperplasia Genetic Test: CYP21A2 Gene and Results

Learn how CFTR carrier testing identifies cystic fibrosis risk, compares panels with sequencing, explains complex variants, and guides partner testing.

Cystic Fibrosis Carrier Test: CFTR Gene Mutations, Risk, and Results

Learn how DMD gene testing diagnoses Duchenne muscular dystrophy, detects deletions and sequence variants, explains results, and guides family care.

Duchenne Muscular Dystrophy Genetic Test: DMD Gene Mutations and Results

Understand Ehlers-Danlos genetic testing for COL5A1, COL5A2, and COL3A1, including classic and vascular EDS results, negative panels, VUS findings, family risk, and next steps.

Ehlers-Danlos Syndrome Genetic Test: COL5A1, COL5A2, COL3A1, and Results

Learn how expanded carrier screening evaluates genetic disease risk, how panel genes and methods differ, what positive and negative results mean, and how partner findings guide pregnancy options.

Expanded Carrier Screening Test: Genetic Disease Risk, Genes, and Results

Understand Fabry disease GLA genetic testing, including classic and late-onset symptoms, enzyme and lyso-Gb3 results, variant interpretation, X-linked family risk, treatment relevance, and next steps.

Fabry Disease Genetic Test: GLA Gene Mutations, Symptoms, and Results

Learn what an ELP1 familial dysautonomia carrier test checks, how positive and negative results affect pregnancy risk, and which follow-up steps matter.

Familial Dysautonomia Carrier Test: ELP1 Gene, Carrier Risk, and Results

Understand what an MEFV genetic test can show, how one or two variants affect an FMF diagnosis, and why negative or uncertain results need clinical context.

Familial Mediterranean Fever Genetic Test: MEFV Gene Mutations and Results

Learn how targeted familial variant testing works, what positive and true negative results mean, and why the original genetic report is essential for accurate cascade testing.

Familial Variant Genetic Test: Known Mutation, Targeted Testing, and Results

Understand FMR1 CGG repeat ranges, premutation carrier risks, maternal expansion, AGG interruptions, and next steps after a Fragile X carrier test.

Fragile X Carrier Test: FMR1 Gene, CGG Repeats, and Results

Understand GBA1 testing for Gaucher disease, carrier and partner risk, pseudogene limitations, two-variant results, residual risk, and Parkinson susceptibility.

Gaucher Disease Genetic Test: GBA1 Gene Mutations, Carrier Risk, and Results

Learn how hemoglobinopathy carrier screening identifies sickle cell trait, alpha- and beta-thalassemia, partner risk, confusing patterns, and pregnancy options.

Hemoglobinopathy Carrier Screening Test: Sickle Cell Disease, Thalassemia, and Results

Understand hereditary cancer screening for BRCA1/BRCA2, Lynch syndrome, and APC, including test selection, positive and negative results, VUS findings, and family risk.

Hereditary Cancer Genetic Screening Test: BRCA1/BRCA2, Lynch Syndrome, APC, and Results

Understand GJB2, GJB6-region, and mitochondrial hearing-loss testing, including carrier findings, maternal inheritance, aminoglycoside risk, panel limits, and family results.

Hereditary Hearing Loss Genetic Test: GJB2, GJB6, Mitochondrial DNA, and Results

Understand HFE C282Y and H63D results, iron studies, penetrance, liver-risk assessment, family testing, and when hereditary hemochromatosis treatment is appropriate.

Hereditary Hemochromatosis Genetic Test: HFE Gene, C282Y, H63D, and Results

1...434445...93 Page 44 of 93